Activation of mTOR signaling pathway associated with adverse prognostic factors of epithelial ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Activation of mTOR signaling pathway associated with adverse prognostic factors of epithelial ovarian cancer

Published:2011-04 Issue:1 Volume:121 Page:8-12
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

No Jae Hong,Jeon Yong-Tark,Park In-Ae,Kim Yong-Beom,Kim Jae Weon,Park Noh-Hyun,Kang Soon-Beom,Han Jae Yong,Lim Jeong Mook,Song Yong-Sang

Funder

MEST

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference24 articles.

1. Cancer statistics, 2008;Jemal;CA Cancer J Clin,2008

2. Beyond chemotherapy: targeted therapies in ovarian cancer;Yap;Nat Rev Cancer,2009

3. The TOR pathway: a target for cancer therapy;Bjornsti;Nat Rev Cancer,2004

4. mTOR, translation initiation and cancer;Mamane;Oncogene,2006

5. AKT and mTOR phosphorylation is frequently detected in ovarian cancer and can be targeted to disrupt ovarian tumor cell growth;Altomare;Oncogene,2004

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the mTOR Signalling Pathway and Its Inhibitory Scope in Cancer;Pharmaceuticals;2023-07-14

2. Dual mTORC1/2 inhibitor AZD2014 diminishes myeloid-derived suppressor cells accumulation in ovarian cancer and delays tumor growth;Cancer Letters;2021-12

3. Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer;Cancer Epidemiology Biomarkers & Prevention;2021-06-23

4. Upregulation of Rab31 is associated with poor prognosis and promotes colorectal carcinoma proliferation via the mTOR/p70S6K/Cyclin D1 signalling pathway;Life Sciences;2020-09

5.

Nanotechnology-Based Targeting of mTOR Signaling in Cancer

;International Journal of Nanomedicine;2020-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3